Anlctinib Hydrochloride Capsules

This product is used for non-small cell lung cancer, small cell lung cancer, soft tissue sarcoma and medullary thyroid cancer.
It should not be used by people who are allergic to any of the ingredients of this product, patients with central squamous cell lung cancer or patients with a high risk of hemoptysis, patients with severe liver and kidney dysfunction, and pregnant and lactating women.
This product should be taken according to the course of treatment until the disease progresses or intolerable adverse reactions occur. … Details 
Comprehensive interpretation of Anlotinib Hydrochloride Capsules

Effects:
This product is used for non-small cell lung cancer, small cell lung cancer, soft tissue sarcoma and medullary thyroid cancer.
Dosage and administration:
The recommended dose of this product is 12 mg each time, once a day, orally before breakfast. Take the medicine continuously for 2 weeks and stop for 1 week, that is, 3 weeks (21 days) as a course of treatment. Until the disease progresses or intolerable adverse reactions occur. The same drugs produced by different manufacturers may have inconsistent instructions. If you find inconsistencies in the instructions before taking the medicine, please consult a doctor or pharmacist in time.
Contraindications:
Contraindicated during pregnancy and lactation. Contraindicated if allergic to this product. Use with caution if liver or kidney function is impaired.
Related dosage forms:
Capsules